日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Application of systems biology to identify pharmacological mechanisms of thrombotic microangiopathy evoked by combined activated prothrombin complex concentrate and emicizumab

应用系统生物学方法鉴定活化凝血酶原复合物浓缩物和艾美赛珠单抗联合用药诱发血栓性微血管病的药理机制

Valls, Raquel; Wagg, Jonathan; Paz-Priel, Ido; Man, Gabriel; Artigas, Laura; Jaccard, Georges; Coma, Mireia; Schmitt, Christophe

Surgical outcomes in people with hemophilia A taking emicizumab prophylaxis: experience from the HAVEN 1-4 studies

接受艾美赛珠单抗预防治疗的A型血友病患者的手术结局:来自HAVEN 1-4研究的经验

Kruse-Jarres, Rebecca; Peyvandi, Flora; Oldenburg, Johannes; Chang, Tiffany; Chebon, Sammy; Doral, Michelle Y; Croteau, Stacy E; Lambert, Thierry; Kempton, Christine L; Pipe, Steven W; Ko, Richard H; Trzaskoma, Benjamin; Dhalluin, Christophe; Bienz, Nives Selak; Niggli, Markus; Lehle, Michaela; Paz-Priel, Ido; Young, Guy; Jiménez-Yuste, Víctor

Effect of emicizumab prophylaxis on bone and joint health markers in people with haemophilia A without factor VIII inhibitors in the HAVEN 3 study

HAVEN 3 研究中,艾美赛珠单抗预防治疗对无 VIII 因子抑制剂的 A 型血友病患者骨骼和关节健康标志物的影响

Kiialainen, Anna; Niggli, Markus; Kempton, Christine L; Castaman, Giancarlo; Chang, Tiffany; Paz-Priel, Ido; Adamkewicz, Joanne I; Levy, Gallia G

Low immunogenicity of emicizumab in persons with haemophilia A

艾美赛珠单抗在A型血友病患者中具有低免疫原性

Schmitt, Christophe; Emrich, Thomas; Chebon, Sammy; Fernandez, Elena; Petry, Claire; Yoneyama, Koichiro; Kiialainen, Anna; Howard, Monet; Niggli, Markus; Paz-Priel, Ido; Chang, Tiffany

Patient preference for emicizumab versus prior factor therapy in people with haemophilia A: Results from the HAVEN 3 and HAVEN 4 studies

A型血友病患者对艾美赛珠单抗治疗的偏好与既往因子治疗的偏好:HAVEN 3和HAVEN 4研究的结果

Parnes, Aric; Mahlangu, Johnny N; Pipe, Steven W; Paz-Priel, Ido; Lehle, Michaela; Trask, Peter C; Jiménez-Yuste, Víctor

Development and testing of the Satisfaction Questionnaire with Intravenous or Subcutaneous Hemophilia Injection and results from the Phase 3 HAVEN 3 study of emicizumab prophylaxis in persons with haemophilia A without FVIII inhibitors

静脉或皮下注射血友病药物满意度问卷的开发和测试,以及针对无FVIII抑制剂的A型血友病患者使用emicizumab预防治疗的3期HAVEN 3研究结果

Kempton, Christine; Trask, Peter; Parnes, Aric; Niggli, Markus; Campinha-Bacote, Avrita; U Callaghan, Michael; O'Connell, Niamh; Paz-Priel, Ido; Mahlangu, Johnny N

The effect of emicizumab prophylaxis on long-term, self-reported physical health in persons with haemophilia A without factor VIII inhibitors in the HAVEN 3 and HAVEN 4 studies

在HAVEN 3和HAVEN 4研究中,艾美赛珠单抗预防治疗对无VIII因子抑制剂的A型血友病患者长期自我报告的身体健康状况的影响

Skinner, Mark W; Négrier, Claude; Paz-Priel, Ido; Chebon, Sammy; Jiménez-Yuste, Victor; Callaghan, Michael U; Lehle, Michaela; Niggli, Markus; Mahlangu, Johnny; Shapiro, Amy; Shima, Midori; Campinha-Bacote, Avrita; Levy, Gallia G; Oldenburg, Johannes; von Mackensen, Sylvia; Pipe, Steven W

Drugs to reduce bleeding and transfusion in adults undergoing cardiac surgery: a systematic review and network meta‐analysis

用于减少成人心脏手术出血和输血的药物:系统评价和网络荟萃分析

Callaghan, Michael U; Negrier, Claude; Paz-Priel, Ido; Chang, Tiffany; Chebon, Sammy; Lehle, Michaela; Mahlangu, Johnny; Young, Guy; Kruse-Jarres, Rebecca; Mancuso, Maria Elisa; Niggli, Markus; Howard, Monet; Bienz, Nives Selak; Shima, Midori; Jiménez-Yuste, Victor; Schmitt, Christophe; Asikanius, Elina; Levy, Gallia G; Pipe, Steven W; Oldenburg, Johannes; Beverly, Anair; Ong, Giok; Wilkinson, Kirstin L; Doree, Carolyn; Welton, Nicky J; Estcourt, Lise J

C/EBPβ regulates sensitivity to bortezomib in prostate cancer cells by inducing REDD1 and autophagosome-lysosome fusion

C/EBPβ通过诱导REDD1和自噬体-溶酶体融合调节前列腺癌细胞对硼替佐米的敏感性

David J Barakat, Janet Mendonca, Theresa Barberi, Jing Zhang, Sushant K Kachhap, Ido Paz-Priel, Alan D Friedman

CCAAT/Enhancer binding protein β controls androgen-deprivation-induced senescence in prostate cancer cells

CCAAT/增强子结合蛋白 β 控制前列腺癌细胞雄激素剥夺诱导的衰老

D J Barakat, J Zhang, T Barberi, S R Denmeade, A D Friedman, I Paz-Priel